This Phase III.

AP, Kaiser Permanente initiate clinical trial to judge the efficacy of Promescent lidocaine spray Absorption Pharmaceuticals LLC in collaboration with Kaiser Permanente announced today the initiation of a clinical trial to evaluate the efficacy of Promescent lidocaine spray for guys with premature ejaculation . This Phase III, double blind, placebo-controlled, randomized research will measure the intravaginal ejaculatory latency period for subjects aged 18 and old online pharmacy .

Kaiser Health Information, an independent news service editorially, is a scheduled plan of the Kaiser Family members Foundation, a nonpartisan healthcare policy research organization unaffiliated with Kaiser Permanente.. AP reports on ‘significant’ clarification of Pope’s comments about condoms to avoid HIV The Associated Press/Washington Post reports that after questions arose about Pope Benedict XVI’s comments on the use of condoms to avoid HIV, which one translation ‘implied that he was discussing homosexual sex primarily, when condoms aren’t being used as a form of contraception,’ Vatican spokesman, the Rev. Federico Lombardi ‘told reporters Tuesday that he asked the pope whether he designed his responses to only apply to male prostitutes.